| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Cell Physiology [H. N., T. H., T. T., S. Y.], Atomic Disease Institute and First Department of Internal Medicine [K. M., S. N.], Nagasaki University School of Medicine, 1-12-4 Sakamoto, Nagasaki, 852 and Ito Hospital, 150, Tokyo [N. I., K. I.], Japan
We investigated the sensitivity and sequential events that take place in thyroid epithelial cells after irradiation. Cell survival ratios at a dose of 2 Gy were 18 ± 2.5%, 58 ± 1.0%, 59 ± 1.5%, and 98 ± 1.8% in primary thyroid cells, papillary thyroid carcinoma cells, follicular thyroid carcinoma cells, and anaplastic thyroid carcinoma cells, respectively. Thyroid carcinoma cell lines carrying mutations in the p53 gene were resistant to ionizing radiation. Although irradiated cells were accumulated at G1 in primary thyroid cells even after low-dose irradiation (0.2 Gy), this phenomenon was not observed in the thyroid carcinoma cell lines. Wild-type p53 expression in primary thyroid cell was increased following irradiation, but mutated p53 in the thyroid carcinoma cell lines was unchanged. To clarify the signal transduction in the G1 arrest following irradiation, levels of expression of the p53 putative downstream effectors GADD45 and WAF1/Cip1 were examined. Despite the consistent level of GADD45 mRNA, the level of WAF1/Cip1 transcripts was increased in a radiation dose-dependent manner in primary thyroid cells. This increase in the WAF1/Cip1 mRNA level was observed 30 min after irradiation and continued for at least 48 h. A mobility shift assay performed using the sequence of the putative p53 DNA binding site on the WAF1/Cip1 and GADD45 genes as a probe showed that nuclear protein extracted from primary thyroid cells, anti-p53 antibody, and probe oligonucleotide-bound complex was clearly shifted. An increase in binding activity of the p53/antibody/DNA complex was observed following irradiation. In contrast, the nuclear extract from thyroid carcinoma cells could not bind the specific DNA site, suggesting that mutant p53 has lost its binding ability. Actinomycin D inhibited WAF1/Cip1 and GADD45 mRNA levels and cycloheximide stimulated up-regulation of both basal mRNA levels, but an additional increase of the mRNA expression following irradiation was observed only in the WAF1/Cip1 gene. These data suggest that p53 in postradiation acts at a transcriptional level on WAF1/Cip1 gene expression and that de novo protein synthesis is not required for this effect.
These results suggest that the p53-WAF1/Cip1 pathway may play a central role in induction of G1 arrest following irradiation in human thyroid epithelial cells.
1 This work was supported by Grants-in-Aid 06671039 (H. N.) and 06454340 (S. Y.) from the Ministry of Education, Culture, and Science of Japan.
2 To whom requests for reprints should be addressed.
Received 11/29/94. Accepted 3/20/95.
This article has been cited by other articles:
![]() |
Y. Xue, S. Wang, and X. Feng Influence of Magnesium Ion on the Binding of p53 DNA-Binding Domain to DNA-Response Elements J. Biochem., July 1, 2009; 146(1): 77 - 85. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Suzuki, S. Sadahiro, M. Fukasawa, K. Ishikawa, A. Kamijo, S. Yasuda, H. Makuuchi, Y. Ohizumi, and C. Murayama Predictive Factors of Tumor Shrinkage and Histological Regression in Patients who Received Preoperative Radiotherapy for Rectal Cancer Jpn. J. Clin. Oncol., December 1, 2004; 34(12): 740 - 746. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Pizzoferrato, Y. Liu, A. Gambotto, M. J. Armstrong, M. T. Stang, W. E. Gooding, S. M. Alber, S. H. Shand, S. C. Watkins, W. J. Storkus, et al. Ectopic Expression of Interferon Regulatory Factor-1 Promotes Human Breast Cancer Cell Death and Results in Reduced Expression of Survivin Cancer Res., November 15, 2004; 64(22): 8381 - 8388. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Starenki, H. Namba, V. Saenko, A. Ohtsuru, and S. Yamashita Inhibition of Nuclear Factor-{kappa}B Cascade Potentiates the Effect of a Combination Treatment of Anaplastic Thyroid Cancer Cells J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 410 - 418. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Doherty, S. R. McKeown, V. McKelvey-Martin, C. S. Downes, A. Atala, J. J. Yoo, D. A. Simpson, and W. K. Kaufmann Cell Cycle Checkpoint Function in Bladder Cancer J Natl Cancer Inst, December 17, 2003; 95(24): 1859 - 1868. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. I. Rogounovitch, V. A. Saenko, Y. Shimizu-Yoshida, A. Yu. Abrosimov, E. F. Lushnikov, P. O. Roumiantsev, A. Ohtsuru, H. Namba, A. F. Tsyb, and S. Yamashita Large Deletions in Mitochondrial DNA in Radiation-associated Human Thyroid Tumors Cancer Res., December 1, 2002; 62(23): 7031 - 7041. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Nagayama, H. Yokoi, K. Takeda, M. Hasegawa, E. Nishihara, H. Namba, S. Yamashita, and M. Niwa Adenovirus-Mediated Tumor Suppressor p53 Gene Therapy for Anaplastic Thyroid Carcinoma in Vitro and in Vivo J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 4081 - 4086. [Abstract] [Full Text] |
||||
![]() |
Q. A. Khan and A. Dipple Diverse chemical carcinogens fail to induce G1 arrest in MCF-7 cells Carcinogenesis, August 1, 2000; 21(8): 1611 - 1618. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Moretti, S. Nanni, A. Farsetti, M. Narducci, M. Crescenzi, S. Giuliacci, A. Sacchi, and A. Pontecorvi Effects of Exogenous p53 Transduction in Thyroid Tumor Cells with Different p53 Status J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 302 - 308. [Abstract] [Full Text] |
||||
![]() |
T. Hara, H. Namba, N. Takamura, T.-T. Yang, Y. Nagayama, S. Fukata, K. Kuma, N. Ishikawa, K. Ito, and S. Yamashita Thyrotropin Regulates c-Jun N-Terminal Kinase (JNK) Activity through Two Distinct Signal Pathways in Human Thyroid Cells Endocrinology, April 1, 1999; 140(4): 1724 - 1730. [Abstract] [Full Text] |
||||
![]() |
R. V. Lloyd, L. A. Erickson, L. Jin, E. Kulig, X. Qian, J. C. Cheville, and B. W. Scheithauer p27kip1: A Multifunctional Cyclin-Dependent Kinase Inhibitor with Prognostic Significance in Human Cancers Am. J. Pathol., February 1, 1999; 154(2): 313 - 323. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Narimatsu, Y. Nagayama, K. Akino, M. Yasuda, T. Yamamoto, T.-t. Yang, A. Ohtsuru, H. Namba, S. Yamashita, H. Ayabe, et al. Therapeutic Usefulness of Wild-Type p53 Gene Introduction in a p53-Null Anaplastic Thyroid Carcinoma Cell Line J. Clin. Endocrinol. Metab., October 1, 1998; 83(10): 3668 - 3672. [Abstract] [Full Text] |
||||
![]() |
K. Tanaka, Y. Nagayama, T. Nakano, N. Takamura, H. Namba, S. Fukada, K. Kuma, S. Yamashita, and M. Niwa Expression Profile of Receptor-Type Protein Tyrosine Kinase Genes in the Human Thyroid Endocrinology, March 1, 1998; 139(3): 852 - 858. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Nishihara, Y. Nagayama, F. Mawatari, K. Tanaka, H. Namba, M. Niwa, and S. Yamashita Retrovirus-Mediated Herpes Simplex Virus Thymidine Kinase Gene Transduction Renders Human Thyroid Carcinoma Cell Lines Sensitive to Ganciclovir and Radiation in Vitro and in Vivo Endocrinology, November 1, 1997; 138(11): 4577 - 4583. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Nagaich, V. B. Zhurkin, H. Sakamoto, A. A. Gorin, G. M. Clore, A. M. Gronenborn, E. Appella, and R. E. Harrington Architectural Accommodation in the Complex of Four p53 DNA Binding Domain Peptides with the p21/waf1/cip1 DNA Response Element J. Biol. Chem., June 6, 1997; 272(23): 14830 - 14841. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Nagaich, E. Appella, and R. E. Harrington DNA Bending Is Essential for the Site-specific Recognition of DNA Response Elements by the DNA Binding Domain of the Tumor Suppressor Protein p53 J. Biol. Chem., June 6, 1997; 272(23): 14842 - 14849. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ohnishi, X. Wang, K. Ohnishi, H. Matsumoto, and A. Takahashi p53-dependent Induction of WAF1 by Heat Treatment in Human Glioblastoma Cells J. Biol. Chem., June 14, 1996; 271(24): 14510 - 14513. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |